Use of neoadjuvant paclitaxel in breast angiosarcoma—Impact on surgical resection and response rates

Ähnliche Einträge

• Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local perspective
  von: Marc W. Fromer, et al.
  Veröffentlicht: (2024)
• Neoadjuvant chemotherapy for resectable gastric cancer is associated with better outcomes than neoadjuvant chemoradiation
  von: Hideo Takahashi, et al.
  Veröffentlicht: (2024)
• Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology
  von: Estefania Roldan‐Vasquez, et al.
  Veröffentlicht: (2024)
• Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology: Correspondence
  von: Hinpetch Daungsupawongm, et al.
  Veröffentlicht: (2024)
• Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi‐institutional analysis
  von: Haleh Amirian, et al.
  Veröffentlicht: (2024)